Patents/Assignees

Takeda Pharmaceutical Company Limited

256 patents in portfolio

US12152027utility2024
Heterocyclic Compound
0 cites
US12144809utility2024
Treatment of Prostate Cancer
0 cites
US12135329utility2024
Peptide Quantitation Assay for Differentiating Full-length High Molecular Weight Kininogen (HMWK) and Cleaved HMWK
0 cites
USD1049371design2024
Infusion Pump Cassette
0 cites
US12128090utility2024
Methods of Prophylactic Treatment Using Recombinant VWF (rvwf)
0 cites
US12128102utility2024
Constrained Conditionally Activated Binding Proteins
0 cites
US12121569utility2024
Methods and Compositions for CNS Delivery of Iduronate-2-sulfatase
0 cites
US12122815utility2024
GIP Receptor Agonist Peptide Compounds and Uses Thereof
0 cites
US12110343utility2024
Anti-plasma Kallikrein Antibodies
0 cites
US12097198utility2024
Treatment of Prostate Cancer
0 cites
US12097306utility2024
Conformal Coating of Biological Surfaces
0 cites
US12097199utility2024
Administration of Sumo-activating Enzyme Inhibitor and Anti-cd20 Antibodies
0 cites
US12091410utility2024
Heterocyclic Compound
0 cites
US12091675utility2024
Gene Therapy of Hemophilia a Using Viral Vectors Encoding Recombinant FVIII Variants with Increased Expression
0 cites
US12094109utility2024
Image Scoring for Intestinal Pathology
0 cites
US12084431utility2024
Pharmaceutical Salts of Pyrimidine Derivatives and Method of Treating Disorders
0 cites
US12084436utility2024
Heterocyclic Compound
0 cites
US12084515utility2024
Compositions and Methods for Treatment of Diabetic Macular Edema
0 cites
US12077522utility2024
Heterocyclic Compound and Application Thereof
0 cites
US12071434utility2024
Heterocyclic Compound
0 cites

← PreviousPage 7 of 13Next →